Seaspine Holdings Corp (SPNE): Keith Valentine , CEO of Seaspine Holdings Corp purchased 10,000 shares on May 20, 2016. The Insider buying transaction was reported by the company on May 24, 2016 to the Securities and Exchange Commission. The shares were purchased at $10.15 per share for a total value of $101,550.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 24, 2016, Keith Valentine (CEO) purchased 10,000 shares at $10.15 per share price.On May 23, 2016, John J. Bostjancic (CFO) purchased 5,000 shares at $10.25 per share price.Also, On Sep 9, 2015, John J. Winge (VP, Sales) purchased 5,315 shares at $15.21 per share price.On Aug 31, 2015, Brian D. Baker (VP, Global Operations) purchased 4,600 shares at $14.96 per share price.
SeaSpine Holdings Corp: On Friday, May 20, 2016 heightened volatility was witnessed in SeaSpine Holdings Corp which led to swings in the share price. The shares opened for trading at $10.27 and hit $10.65 on the upside , eventually ending the session at $10.35, with a gain of 1.47% or 0.15 points. The heightened volatility saw the trading volume jump to 50,628 shares. The 52-week high of the share price is $26 and the company has a market cap of $114,813 M . The 52-week low of the share price is at $9.8.
SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company has a portfolio of orthobiologics and spinal fusion hardware solutions for neurosurgeons and orthopedic spine surgeons which can be used to perform fusion procedures in the lumbar thoracic and cervical spine. The Company’s orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following surgery. The Company’s spinal fusion hardware portfolio consists of a line of products for minimally invasive surgery (MIS) complex spine deformity and degenerative procedures. The Company’s products include Accell Evo3 OsteoSparx Accell Connexus Zuma-C Anterior Cervical Fixation System Zuma IBD OsSatura TCP and Coral MIS among others.